Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).
Clinical trial NCT02210364 · COMPLETED
Trial details
- NCT number
- NCT02210364
- Sponsor
- PharmaMar
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-10-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.